Gyre Therapeutics Inc (GYRE)

R&D Expenses

$19.14M

Quarterly · Period ending: · USD

GYRE logo

GYRE R&D Expenses

Latest reported$19.14M
GYRE Quarterly R&D Expenses ($5.09M → $19.14M)
High-resolution chart · PNG

GYRE r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
19,136,000
6,738,000
4,815,000
2,363,000
8,351,000
3,095,000
3,712,000
2,775,000
3,355,000
2,182,000
4,568,000
3,009,000
3,568,000
2,635,000
6,218,152
6,282,994
1,804,000
9,590,000
16,135,000
20,267,000
15,344,000
17,013,000
14,511,000
12,249,000
12,906,000
13,264,000
10,793,000
9,927,000
11,111,000
12,027,000
8,239,000
5,575,000
3,889,000
3,771,000
3,561,000
3,805,000
3,401,000
2,061,000
3,112,000
3,396,000
2,752,000
2,286,000
1,766,000
1,486,000
366,000
2,064,000
-11,876,000
-11,577,000
-8,824,000
9,080,000
10,754,000
10,312,000
9,454,000
8,320,000
12,340,000
6,434,000
12,512,000
17,801,000
26,069,000
25,444,000
20,185,000
23,517,000
22,488,000
17,329,000
14,122,000
10,607,000
10,010,000
9,625,000
11,049,000
9,495,000
10,664,753
10,717,029
10,517,636
9,081,582
9,913,299
9,436,530
9,079,328
6,190,337
7,134,376
5,297,059
4,595,634
4,760,804
5,643,633
6,226,301
7,287,750
5,093,076
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.